HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiation therapy for pineal and suprasellar germ cell tumors.

Abstract
Radiation therapy (XRT) was used in the treatment of 25 patients with tumors of the pineal and suprasellar locations. A tissue diagnosis was obtained before XRT in 5 patients, and 20 were irradiated without histologic verification. The overall survival rate is 80% (76% with no evidence of disease [NED]). Megavoltage XRT was delivered to the entire neuraxis in 22 patients, and 86% (19/22) are alive from 4 to 88 months (median, 30 months) after treatment. In two of three patients treated only to local fields, tumor recurred in the spine; both are dead of disease. Biopsy-proven germinomas and multiple midline tumors responded favorably to XRT, whereas solitary pineal tumors and teratomas with marker positivity (human chorionic gonadotropin, alpha-fetoprotein) did not respond as well. The endocrinologic presentation, tumor marker status, and early response to radiation measured on computed tomography are useful means for selecting patients for radiation therapy.
AuthorsT A Rich, J R Cassady, R D Strand, K R Winston
JournalCancer (Cancer) Vol. 55 Issue 5 Pg. 932-40 (Mar 01 1985) ISSN: 0008-543X [Print] United States
PMID2981605 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Brain (diagnostic imaging)
  • Brain Neoplasms (radiotherapy, surgery)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Neoplasms, Germ Cell and Embryonal (radiotherapy, surgery)
  • Pineal Gland
  • Pinealoma (radiotherapy)
  • Radiotherapy (adverse effects)
  • Teratoma (radiotherapy)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: